Welcome to our dedicated page for Neogen SEC filings (Ticker: NEOG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Neogen Corporation (NEOG) SEC filings page provides access to the company’s official regulatory disclosures filed with the U.S. Securities and Exchange Commission. These documents offer detailed insight into Neogen’s operations in food safety, animal safety, and related markets, as well as its governance, compensation practices, and financial condition.
Neogen uses current reports on Form 8-K to disclose material events such as the appointment of a new President and Chief Executive Officer, changes in the Chief Financial Officer role, director retirements and appointments, and the results of shareholder votes at its annual meeting. Filings describe executive compensation arrangements, including base salary, annual bonus targets, long-term equity incentives, and performance share unit programs tied to metrics like revenue growth, adjusted EBITDA margin expansion, and cash flow conversion.
Investors can also review 8-K filings that furnish earnings press releases, which summarize quarterly and annual results, segment performance for Food Safety and Animal Safety, and non-GAAP measures such as adjusted EBITDA. These filings complement the company’s financial statements by providing narrative context and reconciliations.
On Stock Titan, NEOG filings are updated as they are posted to EDGAR, and AI-powered summaries can help explain key elements of lengthy documents, including annual reports on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K. Users can quickly identify disclosures related to executive and director changes, incentive plans, shareholder meeting outcomes, and other governance matters.
This page is a resource for understanding how Neogen describes its strategy, risk factors, performance metrics, and capital structure in its own words through formal SEC filings, with tools to make complex regulatory content more accessible.
Neogen Corporation reported results from its 2025 Annual Meeting held on October 23, 2025. A total of 195,086,461 of 217,298,626 shares outstanding and entitled to vote were represented.
Shareholders elected four directors: Thierry L. Bernard (For 168,950,135; Withheld 16,330,540), Mikhael Nassif (For 171,847,536; Withheld 13,433,139), Avi Pelossof (For 171,839,634; Withheld 13,441,041), and Andrea F. Wainer (For 169,573,203; Withheld 15,707,472).
The non-binding advisory vote on executive compensation did not pass (For 167,126,873; Against 17,679,601; Abstain 412,667; Broker Non-Vote 9,805,786). Shareholders ratified BDO USA, P.C. as independent auditor for the fiscal year ending May 31, 2026 (For 181,630,320; Against 13,148,285; Abstain 307,856).
Neogen Corp (NEOG) reported an insider equity event. On 10/13/2025, the Chief Legal Officer had 294 RSUs vest and settle into an equal number of common shares (Code M) at a stated price of $6.04 per share. To satisfy tax obligations, 115 shares were withheld/disposed (Code F) at $6.04. Following these transactions, the officer directly owns 49,851 shares.
Neogen Corp (NEOG) reported an insider equity event by a company officer (Former COO). On 10/13/2025, 783 restricted stock units vested and were settled for an equal number of common shares (transaction code M). To satisfy tax withholding, 383 shares were withheld/disposed (code F) at a price listed as $6.04 per share. Following these transactions, the reporting person directly owned 88,858 common shares.
Neogen Corp (NEOG) insider filing reports routine equity compensation activity. An officer (Former CEO) converted 3,063 restricted stock units into common stock on 10/13/2025 (Code M) at $6.04 per share, and recorded a disposition of 865 shares (Code F) at $6.04 per share the same day. After these transactions, the reporting person beneficially owned 332,849 shares, held directly.
The remarks state each RSU is the economic equivalent of one share, and these RSUs vested and were settled for an equal number of common shares on October 13, 2025.
NEOGEN CORP (NEOG) reporting person Amy M. Rocklin had 9,036 restricted stock units vest on
Insider stock vesting and sale by former COO
On
The filing states each RSU equals one share and that vesting and settlement occurred on
Insider stock activity at NEOGEN (NEOG): Former CEO and officer John Edward Adent had 32,936 restricted stock units vest on
Catherine E. Woteki, a director of NEOGEN CORP (NEOG), had
The filing is a routine Section 16 Form 4 reporting the vesting and settlement of equity compensation; it shows an increase in the director’s direct holdings but does not disclose any cash sale or purchase beyond the RSU settlement.
Tobin James P, a director of Neogen Corp (NEOG), had 2,071 restricted stock units vest on
NEOGEN CORP (NEOG) director Rafael A. Rodriguez received 2,071 restricted stock units that vested and were settled into 2,071 shares of common stock on